Subclinical cardiotoxicity in childhood cancer survivors exposed to very low dose anthracycline therapy

K Leger, T Slone, M Lemler, D Leonard… - Pediatric blood & …, 2015 - Wiley Online Library
Background Subclinical cardiotoxicity occurs in childhood cancer survivors following
moderate and high anthracycline doses. However, less is known about the subclinical …

Subclinical cardiotoxicity in childhood cancer survivors exposed to very low dose anthracycline therapy

K Leger, T Slone, M Lemler… - Pediatric Blood …, 2015 - utsouthwestern.elsevierpure.com
Background: Subclinical cardiotoxicity occurs in childhood cancer survivors following
moderate and high anthracycline doses. However, less is known about the subclinical …

Subclinical cardiotoxicity in childhood cancer survivors exposed to very low dose anthracycline therapy.

K Leger, T Slone, M Lemler, D Leonard… - Pediatric Blood & …, 2014 - europepmc.org
Background Subclinical cardiotoxicity occurs in childhood cancer survivors following
moderate and high anthracycline doses. However, less is known about the subclinical …

Subclinical cardiotoxicity in childhood cancer survivors exposed to very low dose anthracycline therapy

K Leger, T Slone, M Lemler… - Pediatric blood & …, 2015 - pubmed.ncbi.nlm.nih.gov
Background Subclinical cardiotoxicity occurs in childhood cancer survivors following
moderate and high anthracycline doses. However, less is known about the subclinical …

Subclinical cardiotoxicity in childhood cancer survivors exposed to very low dose anthracycline therapy

K Leger, T Slone, M Lemler, D Leonard… - Pediatric Blood & …, 2014 - infona.pl
Background Subclinical cardiotoxicity occurs in childhood cancer survivors following
moderate and high anthracycline doses. However, less is known about the subclinical …